Literature DB >> 8400493

The relationship between Helicobacter pylori and oxygen-derived free radicals in the mechanism of duodenal ulceration.

A S Salim1.   

Abstract

This prospective randomized study investigated the possibility that duodenal ulcer relapse associated with Helicobacter Pylori infection is mediated by oxygen-derived free radicals. To this end, the radical scavengers allopurinol (50 mg 4 times daily) and dimethyl sulphoxide (DMSO, 500 mg 4 times daily) were administered orally. One hundred and forty-six consecutive patients with previous symptomatic endoscopy proven duodenal ulceration, which had been shown endoscopically to have healed in the presence of gastric mucosal infection with Helicobacter Pylori, were randomized to receive for the period of one year either placebo, or cimetidine 400 mg at bedtime, or allopurinol, or DMSO. In one hundred and twenty-six patients evaluable for efficacy, the cumulative relapse at one year was: placebo 47%, cimetidine 24%, allopurinol 6% and DMSO 6%. Cimetidine was significantly effective in preventing the relapse (p < 0.01), however allopurinol and DMSO were superior to cimetidine in this respect (p < 0.05). In the patients who relapsed, ulcer recurrence tended to occur early in those on placebo and cimetidine and to be evenly distributed over the year in those on free radical scavenging therapy. In all groups, ulcer recurrence throughout the maintenance year was more frequently symptomatic than silent. The incidence of infection with Helicobacter Pylori was not influenced by any of the regimens employed and the bacterium was detected with every relapse noted in this study and during the follow-up endoscopy which was carried out at 6 months and at 12 months during the maintenance year. The results suggest that oxygen-derived free radicals are involved in the relapse of duodenal ulceration in patients infected with Helicobacter Pylori.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8400493     DOI: 10.2169/internalmedicine.32.359

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  10 in total

1.  Motor fluctuations and Helicobacter pylori in Parkinson's disease.

Authors:  Karl-Erik Rahne; Carl Tagesson; Dag Nyholm
Journal:  J Neurol       Date:  2013-09-04       Impact factor: 4.849

Review 2.  New uses for allopurinol.

Authors:  R O Day; D J Birkett; M Hicks; J O Miners; G G Graham; P M Brooks
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

3.  Antimicrobial effects of antioxidants with and without clarithromycin on Helicobacter pylori.

Authors:  Archana Chatterjee; Debasis Bagchi; Taharat Yasmin; Sidney J Stohs
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

4.  Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals.

Authors:  I Walter-Sack; J X de Vries; C Kutschker; A Ittensohn; A Voss
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 5.  Helicobacter pylori.

Authors:  B E Dunn; H Cohen; M J Blaser
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

6.  The bactericidal effects of Lactobacillus acidophilus, garcinol and Protykin compared to clarithromycin, on Helicobacter pylori.

Authors:  Archana Chatterjee; Taharat Yasmin; Debasis Bagchi; Sidney J Stohs
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

7.  Helicobacter pylori-induced oxidative stress and DNA damage in a primary culture of human gastric mucosal cells.

Authors:  Debasis Bagchi; Thomas R McGinn; Xumein Ye; Manashi Bagchi; Roger L Krohn; Archana Chatterjee; Sidney J Stohs
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

8.  Inhibition of Helicobacter pylori in vitro by various berry extracts, with enhanced susceptibility to clarithromycin.

Authors:  Archana Chatterjee; Taharat Yasmin; Debasis Bagchi; Sidney J Stohs
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

9.  Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease.

Authors:  Hasriza Hashim; Shahrul Azmin; Hamizah Razlan; Nafisah Wan Yahya; Hui Jan Tan; M Rizal Abdul Manaf; Norlinah Mohamed Ibrahim
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

10.  Eradication of Helicobacter pylori restores glutathione S-transferase activity and glutathione levels in antral mucosa.

Authors:  A H Oijen; M L Verhulst; H M Roelofs; W H Peters; W A de Boer; J B Jansen
Journal:  Jpn J Cancer Res       Date:  2001-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.